Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (2): 176-180.DOI: 10.3969/j.issn.1673-8640.2024.02.014

Previous Articles     Next Articles

Applicability of CLSI EP09-A3 in 2-method comparison determining serum total triiodothyronine

CHEN Yongwei1, WANG Jing1, YANG Xiaolong2(), HU Fangyu2, LIN Fang2   

  1. 1. Department of Clinical Laboratory,Jiangyuan Hospital Affiliated to Jiangsu Institute of Nuclear Medicine,Wuxi 214063,Jiangsu,China
    2. Development Central Laboratory,Sysmex Wuxi Co. Ltd.,Wuxi 214028,Jiangsu,China
  • Received:2023-03-23 Revised:2023-08-01 Online:2024-02-28 Published:2024-03-26
  • Contact: YANG Xiaolong

Abstract:

Objective To evaluate the applicability of the Clinical and Laboratory Standards Institute(CLSI) guideline EP09-A3 in 2 chemiluminescence immunoassay systems determining serum total triiodothyronine(TT3). Methods Totally,111 serum samples were determined for TT3 and analyzed by System 1 and System 2. Analytical performance and method comparison were performed according to EP09-A3. Outliers were computed by extreme studentized deviate(ESD),and 5 classified regression techniques were performed to evaluate the 2 methods and interpret biases. Results No outliers were determined in this study by visual judgement or ESD. The biases with 95% confidence interval(CI) of medical decision points(0.75 and 1.91 ng·mL-1) were within the allowable total error(TEa)(±12.5%) by applying general linear regression,weighted least square regression,Deming regression and Passing-Bablock regression,and the outcomes were interpreted as type A or B which were acceptable. While the outcome of weighted Deming regression was interpreted as type C which may be judged as unacceptable. Conclusions The results of 2 systems determining TT3 are comparable,and the analysis methods and interpretation of EP09-A3 are more scientific and reasonable.

Key words: EP09-A3, Total triiodothyronine, Method comparison, Medical decision point, Bias

CLC Number: